A recent Phase 4 study also reports that a higher rate of dose reduction was required with the presence of SNP of VEGFR3 rs307826, whereas the SNP VEGFR3 rs307821 was associated with the higher occurrence of hypothyroidism [236]. The gene discussed is FLT4; the disease is hypothyroidism.